MEGAN HATCHER: Open Payments
NPI 1316619034 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 24 payments from 14 companies in 2025. Trend: 2023 $406 · 2024 $485 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 3 | $80 |
| Astellas Pharma US Inc | 3 | $75 |
| MILLICENT US INC | 3 | $66 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Exeltis, USA Inc. | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| Solventum Corporation | 1 | $27 |
| SANOFI PASTEUR INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: ZURZUVAE, Veozah, FEMLYV, SLYND, EVENITY, Lynkuet, PREVENA, Mirena.
Industry payments across GA — which companies pay providers there.
